Exact Mass: 441.2549
Exact Mass Matches: 441.2549
Found 116 metabolites which its exact mass value is equals to given mass value 441.2549
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Leukotriene E3
Leukotriene E3 is an eicosanoid derived from 8,11,14-Eicosatrienoic acid by the 5-Lipoxygenase-Leukotriene Pathway. The eicosanoids are a diverse family of molecules that have powerful effects on cell function. They are best known as intercellular messengers, having autocrine and paracrine effects following their secretion from the cells that synthesize them. The diversity of possible products that can be synthesized from eicosatrienoic acid is due, in part to the variety of enzymes that can act on it. Studies have placed many, but not all, of these enzymes at or inside the nucleus. In some cases, the nuclear import or export of eicosatrienoic acid-processing enzymes is highly regulated. Furthermore, nuclear receptors that are activated by specific eicosanoids are known to exist. Taken together, these findings indicate that the enzymatic conversion of eicosatrienoic acid to specific signaling molecules can occur in the nucleus, that it is regulated, and that the synthesized products may act within the nucleus. Leukotriene E3 is also a by-product of the metabolism of leukotriene C3. Although they are primarily known for their roles in asthma, pain, fever and vascular responses, present evidence indicates that eicosanoids exert relevant effects on immune/inflammatory, as well as structural, cells pertinent to fibrogenesis. (PMID: 7306127, 8142566, 16574479, 15896193)Leukotrienes are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs), and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes), and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signalling pathways. Leukotriene E3 is an eicosanoid derived from 8,11,14-Eicosatrienoic acid by the 5-Lipoxygenase-Leukotriene Pathway. The eicosanoids are a diverse family of molecules that have powerful effects on cell function. They are best known as intercellular messengers, having autocrine and paracrine effects following their secretion from the cells that synthesize them. The diversity of possible products that can be synthesized from eicosatrienoic acid is due, in part to the variety of enzymes that can act on it. Studies have placed many, but not all, of these enzymes at or inside the nucleus. In some cases, the nuclear import or export of eicosatrienoic acid-processing enzymes is highly regulated. Furthermore, nuclear receptors that are activated by specific eicosanoids are known to exist. Taken together, these findings indicate that the enzymatic conversion of eicosatrienoic acid to specific signaling molecules can occur in the nucleus, that it is regulated, and that the synthesized products may act within the nucleus. Leukotriene E3 is also a by-product of the metabolism of leukotriene C3. Although they are primarily known for their roles in asthma, pain, fever and vascular responses, present evidence indicates that eicosanoids exert relevant effects on immune/inflammatory, as well as structural, cells pertinent to fibrogenesis. (PMID: 7306127, 8142566, 16574479, 15896193)
Pentanoic acid, 5-(dipentylamino)-5-oxo-4-((3-quinolinylcarbonyl)amino)-, (R)-
(13R)-11alpha-acetoxy-2alpha-hydroxy-13-isobutyryloxyhetisane|trichodelphinine A
Ile Asn Pro Val
Ile Asn Val Pro
Ile Pro Asn Val
Ile Pro Val Asn
Ile Val Asn Pro
Ile Val Pro Asn
Lys Pro Pro Thr
Lys Pro Thr Pro
Lys Thr Pro Pro
Leu Asn Pro Val
Leu Asn Val Pro
Leu Pro Asn Val
Leu Pro Val Asn
Leu Val Asn Pro
Leu Val Pro Asn
Asn Ile Pro Val
Asn Ile Val Pro
Asn Leu Pro Val
Asn Leu Val Pro
Asn Pro Ile Val
Asn Pro Leu Val
Asn Pro Val Ile
Asn Pro Val Leu
Asn Val Ile Pro
Asn Val Leu Pro
Asn Val Pro Ile
Asn Val Pro Leu
Pro Ile Asn Val
Pro Ile Val Asn
Pro Lys Pro Thr
Pro Lys Thr Pro
Pro Leu Asn Val
Pro Leu Val Asn
Pro Asn Ile Val
Pro Asn Leu Val
Pro Asn Val Ile
Pro Asn Val Leu
Pro Pro Lys Thr
Pro Pro Thr Lys
Pro Gln Val Val
Pro Thr Lys Pro
Pro Thr Pro Lys
Pro Val Ile Asn
Pro Val Leu Asn
Pro Val Asn Ile
Pro Val Asn Leu
Pro Val Gln Val
Pro Val Val Gln
Gln Pro Val Val
Gln Val Pro Val
Gln Val Val Pro
Thr Lys Pro Pro
Thr Pro Lys Pro
Thr Pro Pro Lys
Val Ile Asn Pro
Val Ile Pro Asn
Val Leu Asn Pro
Val Leu Pro Asn
Val Asn Ile Pro
Val Asn Leu Pro
Val Asn Pro Ile
Val Asn Pro Leu
Val Pro Ile Asn
Val Pro Leu Asn
Val Pro Asn Ile
Val Pro Asn Leu
Val Pro Gln Val
Val Pro Val Gln
Val Gln Pro Val
Val Gln Val Pro
Val Val Pro Gln
Val Val Gln Pro
Leukotriene E3
A leukotriene that is leukotriene E4 in which the non-conjugated double bond has been reduced to a single bond.
5-Methyl-3-(9-oxo-1,8-diaza-tricyclo[10.6.1.013,18]nonadeca-12(19),13,15,17-tetraen-10-ylcarbamoyl)-hexanoic acid
Lisinopril diydrate
D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D020011 - Protective Agents > D002316 - Cardiotonic Agents
Lys-Thr-Pro-Pro
A tetrapeptide composed of L-lysine, L-threonine and two L-proline units joined in sequence by peptide linkages.